Testing a new drug in healthy adults
Part of Skin clinical trials.
This study tests a new experimental drug called PG-033 in healthy adults. It helps doctors find out if the drug is safe and how your body processes it at different dose levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- Your weight must be at least 50 kg (110 lbs) for men or 45 kg (99 lbs) for women, and your BMI must be between 19 and 26.
- You need to be generally healthy with no major long-term health problems.
- You must not have taken any medications, supplements, or herbal remedies in the last 2 weeks.
- You must be willing to avoid pregnancy or use effective birth control, and not donate sperm or eggs for a while after the study.
- You need to avoid alcohol, caffeine, grapefruit, and smoking during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new medicine called PG-033 in healthy adults. It checks how the drug moves through the body and how food affects it, to find the safest starting dose for future studies.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
Hear when a new Lichen Simplex Chronicus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.